Pharmaceutical Investing Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan
Pharmaceutical Investing EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update
LaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates
